Evaluation of BCG and new vaccines against tuberculosis

Pediatric Pulmonology

Volumn 24, Issue SUPPL. 16, 1997, Pages 286-287

  Guerin N ^a  

^a International Children's Centre   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

CONFERENCE PAPER; ECONOMIC ASPECT; EUROPE; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; PRIORITY JOURNAL; TUBERCULOSIS; WORLD HEALTH ORGANIZATION; ARTICLE; CHILD; EVALUATION; IMMUNOLOGY; INFANT; MANAGEMENT; PRESCHOOL CHILD; VACCINATION;

BCG VACCINE; CHILD; CHILD, PRESCHOOL; EUROPE; EVALUATION STUDIES; HUMANS; INFANT; POLICY MAKING; TUBERCULOSIS; VACCINATION; WORLD HEALTH ORGANIZATION;

EID: 0031431713     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/ppul.19502308148     Document Type: Conference Paper

References (3)

1. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in thé prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271:698-702.
2. Global Tuberculosis Programme and Global Programme on Vaccines and Immunization Statement on BCG revaccination for the prevention of tuberculosis. WER 1995; 70:229-231.
3. Criteria for discontinuation of vaccination programmes using Bacille Calmette-Guérin (BCG) in countries with a low prevalence of tuberculosis. A statement of the International Union against Tuberculosis and Lung Disease. Tubercle Lung Dis. 1994; 75:179-180.